131 related articles for article (PubMed ID: 18498452)
21. Assessment of the sensitization potential of persulfate salts used for bleaching hair.
Cruz MJ; De Vooght V; Muñoz X; Hoet PH; Morell F; Nemery B; Vanoirbeek JA
Contact Dermatitis; 2009 Feb; 60(2):85-90. PubMed ID: 19207378
[TBL] [Abstract][Full Text] [Related]
22. Assessment of chemical skin-sensitizing potency by an in vitro assay based on human dendritic cells.
Lambrechts N; Vanheel H; Nelissen I; Witters H; Van Den Heuvel R; Van Tendeloo V; Schoeters G; Hooyberghs J
Toxicol Sci; 2010 Jul; 116(1):122-9. PubMed ID: 20375081
[TBL] [Abstract][Full Text] [Related]
23. Potency values from the local lymph node assay: application to classification, labelling and risk assessment.
Loveless SE; Api AM; Crevel RW; Debruyne E; Gamer A; Jowsey IR; Kern P; Kimber I; Lea L; Lloyd P; Mehmood Z; Steiling W; Veenstra G; Woolhiser M; Hennes C
Regul Toxicol Pharmacol; 2010 Feb; 56(1):54-66. PubMed ID: 19733604
[TBL] [Abstract][Full Text] [Related]
24. A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses.
Basketter DA; Lea LJ; Dickens A; Briggs D; Pate I; Dearman RJ; Kimber I
J Appl Toxicol; 1999; 19(4):261-6. PubMed ID: 10439340
[TBL] [Abstract][Full Text] [Related]
25. Characterization and evaluation of a modified local lymph node assay using ATP content as a non-radio isotopic endpoint.
Idehara K; Yamagishi G; Yamashita K; Ito M
J Pharmacol Toxicol Methods; 2008; 58(1):1-10. PubMed ID: 18462956
[TBL] [Abstract][Full Text] [Related]
26. Use of IL-8 release and p38 MAPK activation in THP-1 cells to identify allergens and to assess their potency in vitro.
Mitjans M; Galbiati V; Lucchi L; Viviani B; Marinovich M; Galli CL; Corsini E
Toxicol In Vitro; 2010 Sep; 24(6):1803-9. PubMed ID: 20541004
[TBL] [Abstract][Full Text] [Related]
27. Potency and risk assessment of a skin-sensitizing disperse dye using the local lymph node assay.
Betts CJ; Dearman RJ; Kimber I; Maibach HI
Contact Dermatitis; 2005 May; 52(5):268-72. PubMed ID: 15899000
[TBL] [Abstract][Full Text] [Related]
28. Use of an ex vivo local lymph node assay to assess contact hypersensitivity potential.
Piccotti JR; Kawabata TT
J Immunotoxicol; 2008 Jul; 5(3):271-7. PubMed ID: 18830887
[TBL] [Abstract][Full Text] [Related]
29. An epidermal equivalent assay for identification and ranking potency of contact sensitizers.
Gibbs S; Corsini E; Spiekstra SW; Galbiati V; Fuchs HW; Degeorge G; Troese M; Hayden P; Deng W; Roggen E
Toxicol Appl Pharmacol; 2013 Oct; 272(2):529-41. PubMed ID: 23876969
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of skin sensitization potency of acrylates (methyl acrylate, ethyl acrylate, butyl acrylate, and ethylhexyl acrylate) using the local lymph node assay.
Dearman RJ; Betts CJ; Farr C; McLaughlin J; Berdasco N; Wiench K; Kimber I
Contact Dermatitis; 2007 Oct; 57(4):242-7. PubMed ID: 17868217
[TBL] [Abstract][Full Text] [Related]
31. The local lymph node assay and skin sensitization testing.
Kimber I; Dearman RJ
Methods Mol Biol; 2010; 598():221-31. PubMed ID: 19967517
[TBL] [Abstract][Full Text] [Related]
32. The local lymph node assay: past, present and future.
Kimber I; Dearman RJ; Basketter DA; Ryan CA; Gerberick GF
Contact Dermatitis; 2002 Dec; 47(6):315-28. PubMed ID: 12581276
[TBL] [Abstract][Full Text] [Related]
33. Relating skin sensitizing potency to chemical reactivity: reactive Michael acceptors inhibit NF-κB signaling and are less sensitizing than S(N)Ar- and S(N)2- reactive chemicals.
Natsch A; Haupt T; Laue H
Chem Res Toxicol; 2011 Nov; 24(11):2018-27. PubMed ID: 22023385
[TBL] [Abstract][Full Text] [Related]
34. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
[TBL] [Abstract][Full Text] [Related]
35. Reproducible prediction of contact allergenic potency using the local lymph node assay.
Basketter DA; Cadby P
Contact Dermatitis; 2004 Jan; 50(1):15-7. PubMed ID: 15059097
[TBL] [Abstract][Full Text] [Related]
36. In vitro approaches to the identification and characterization of skin sensitizers.
Basketter D; Maxwell G
Cutan Ocul Toxicol; 2007; 26(4):359-73. PubMed ID: 18058309
[TBL] [Abstract][Full Text] [Related]
37. Human potency predictions for aldehydes using the local lymph node assay.
Basketter DA; Wright ZM; Warbrick EV; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; White IR
Contact Dermatitis; 2001 Aug; 45(2):89-94. PubMed ID: 11553118
[TBL] [Abstract][Full Text] [Related]
38. Skin sensitization potency of isoeugenol and its dimers evaluated by a non-radioisotopic modification of the local lymph node assay and guinea pig maximization test.
Takeyoshi M; Iida K; Suzuki K; Yamazaki S
J Appl Toxicol; 2008 May; 28(4):530-4. PubMed ID: 17929237
[TBL] [Abstract][Full Text] [Related]
39. The local lymph node assay: current position in the regulatory classification of skin sensitizing chemicals.
Basketter DA; Gerberick GF; Kimber I
Cutan Ocul Toxicol; 2007; 26(4):293-301. PubMed ID: 18058304
[TBL] [Abstract][Full Text] [Related]
40. Inter-laboratory validation of the modified murine local lymph node assay based on 5-bromo-2'-deoxyuridine incorporation.
Kojima H; Takeyoshi M; Sozu T; Awogi T; Arima K; Idehara K; Ikarashi Y; Kanazawa Y; Maki E; Omori T; Yuasa A; Yoshimura I
J Appl Toxicol; 2011 Jan; 31(1):63-74. PubMed ID: 20677212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
